Axitinib: Clinical Trials

5 trials of Axitinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 unknown. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Not yet recruiting 1, Unknown 1

Follow Axitinib: new trials by email Literature Review of Axitinib trials Research Report on Axitinib

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma
Fasting mimicking diet, Toripalimab, Axitinib - Carcinoma, Renal Cell, Metastatic Renal Cell Carcinoma
Not applicableNot yet recruitingQilu Hospital of Shandong University432026-04-012026-03-30
Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma
sunitinib or pazopanib, PD-1 inhibitor combined with axitinib - Metastatic Renal Cell Carcinoma
Not applicableUnknownRenJi Hospital5002022-08-012023-04-18
Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy
Avelumab, Axitinib - Cervical Cancer
Not applicableCompletedThe University of Hong Kong232019-06-012025-06-11
Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer
axitinib - Colorectal Carcinoma
Not applicableCompletedGustave Roussy, Cancer Campus, Grand Paris272011-09-012016-02-10
Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials
axitinib, crizotinib - Solid Tumors
Not applicableCompletedPfizer522003-03-072024-12-03

Conditions studied

Carcinoma, Renal Cell (2)  ·  Colorectal Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  Pfizer (1)  ·  Qilu Hospital of Shandong University (1)  ·  RenJi Hospital (1)  ·  The University of Hong Kong (1)

Countries

China (2)  ·  France (2)  ·  Czechia (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Italy (1)  ·  Japan (1)  ·  Russia (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Ka Yu Tse (1)  ·  Michel Ducreux (1)  ·  Nengwang Yu (1)

NIH funding

2005 (1)